Lipoic acid
- Generic Name
- Lipoic acid
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C8H14O2S2
- CAS Number
- 1200-22-2
- Unique Ingredient Identifier
- VLL71EBS9Z
- Background
A vitamin-like antioxidant.
- Indication
For nutritional supplementation, also for treating dietary shortage or imbalance.
- Associated Conditions
- Diabetic Neuropathies, Type 2 Diabetes Mellitus
- Associated Therapies
- Dietary and Nutritional Therapies, Nutritional supplementation
Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 or 2)
- First Posted Date
- 2009-09-15
- Last Posted Date
- 2022-02-07
- Lead Sponsor
- MEDA Pharma GmbH & Co. KG
- Target Recruit Count
- 460
- Registration Number
- NCT00977483
- Locations
- 🇺🇸
Mayo Clinic Arizona, Scottsdale, Arizona, United States
🇳🇱University Hospital Utrecht Department of Internal Medicine, Utrecht, Netherlands
🇺🇸Loyola University Medical Center, Maywood, Illinois, United States
Lipoic Acid to Treat Chronic Inflammatory Demyelinating Polyneuropathy
- Conditions
- Interventions
- First Posted Date
- 2009-08-20
- Last Posted Date
- 2020-08-19
- Lead Sponsor
- Oregon Health and Science University
- Target Recruit Count
- 7
- Registration Number
- NCT00962429
- Locations
- 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States
Effect of Long Term α-Lipoic Acid Treatment on Endothelial Function in Patients With Type 2 Diabetes
- Conditions
- First Posted Date
- 2007-06-25
- Last Posted Date
- 2018-03-20
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 30
- Registration Number
- NCT00490867
Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin
- Conditions
- Interventions
- First Posted Date
- 2007-05-24
- Last Posted Date
- 2014-03-07
- Lead Sponsor
- US Department of Veterans Affairs
- Target Recruit Count
- 39
- Registration Number
- NCT00477607
- Locations
- 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States
🇺🇸VA Medical Center, Portland, Portland, Oregon, United States
The Effects of Lipoic Acid on Glycaemic Control in Type 2 Diabetes
- First Posted Date
- 2006-11-14
- Last Posted Date
- 2024-05-29
- Lead Sponsor
- University of Edinburgh
- Registration Number
- NCT00398892
- Locations
- 🇬🇧
Diabetes Department, St John's Hospital, Livingston, Scotland, United Kingdom
Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Symptomatic Diabetic Neuropathy (SYDNEY 2)
- Conditions
- First Posted Date
- 2006-05-22
- Last Posted Date
- 2022-02-07
- Lead Sponsor
- MEDA Pharma GmbH & Co. KG
- Target Recruit Count
- 170
- Registration Number
- NCT00328601
- Locations
- 🇷🇺
Chair of Nervous Diseases of IM Sechenov Moscow Medical Academy at City Clinical Hospital, Moscow, Russian Federation
🇮🇱Haddassah Medical Center Ein Kerem, Diabetes Unit, Jerusalem, Israel
🇷🇺Chair of Endocrinology and Diabetology of Russian Medical Academy of Postgraduate Education at Central Clinical Hospital of Ministry of Communication RF, Moscow, Russian Federation
Tocopherols and Alpha Lipoic Acid Treatment Chronic Kidney Disease (TALAT)
- Conditions
- Interventions
- First Posted Date
- 2006-03-30
- Last Posted Date
- 2009-07-09
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 62
- Registration Number
- NCT00308971
- Locations
- 🇺🇸
Maine Medical Center, Portland, Maine, United States
🇺🇸Vanderbilt University Medical Center, Nashville, Tennessee, United States
Provision of Antioxidant Therapy in Hemodialysis (PATH) Study
- Conditions
- Interventions
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2012-01-11
- Lead Sponsor
- Vanderbilt University
- Target Recruit Count
- 385
- Registration Number
- NCT00237718
- Locations
- 🇺🇸
Fresenius Medical Care North America, Nashville, Tennessee, United States
Cardiovascular Disease (CVD) Risk and Prevention in Early Glucose Intolerance
- Conditions
- Interventions
- First Posted Date
- 2005-07-22
- Last Posted Date
- 2013-12-05
- Lead Sponsor
- Emory University
- Target Recruit Count
- 84
- Registration Number
- NCT00122447
- Locations
- 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
🇺🇸Grady Health System, Atlanta, Georgia, United States
Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for Cancer
- Conditions
- Interventions
- First Posted Date
- 2005-06-03
- Last Posted Date
- 2014-04-08
- Lead Sponsor
- M.D. Anderson Cancer Center
- Target Recruit Count
- 244
- Registration Number
- NCT00112996
- Locations
- 🇺🇸
Hembree Mercy Cancer Center at St. Edward Mercy Medical Center, Fort Smith, Arkansas, United States
🇺🇸Cancer Research for the Ozarks, Springfield, Missouri, United States
🇺🇸CCOP - Scott and White Hospital, Temple, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.